MRTX
Mirati Therapeutics, Inc. Common Stock
MRTX
MRTX
Delisted
MRTX was delisted on the 22nd of January, 2024.
207 hedge funds and large institutions have $2.38B invested in Mirati Therapeutics, Inc. Common Stock in 2023 Q2 according to their latest regulatory filings, with 27 funds opening new positions, 82 increasing their positions, 67 reducing their positions, and 41 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
less capital invested
Capital invested by funds: $ → $
6% less funds holding
Funds holding: 221 → 207 (-14)
34% less first-time investments, than exits
New positions opened: 27 | Existing positions closed: 41
Holders
207
Holding in Top 10
7
Calls
$33.6M
Puts
$11.3M
Top Buyers
| 1 | +$30M | |
| 2 | +$28.7M | |
| 3 | +$25M | |
| 4 |
Assenagon Asset Management
Senningerberg,
Luxembourg
|
+$20M |
| 5 |
AG
Artal Group
Luxembourg
|
+$18.7M |
Top Sellers
| 1 | -$30.9M | |
| 2 | -$24M | |
| 3 | -$18.6M | |
| 4 |
CC
Casdin Capital
New York
|
-$17.6M |
| 5 |
PHS
PFM Health Sciences
San Francisco,
California
|
-$11.9M |